geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 29744

Chapter 29744 provides bibliographic information on scholary research in geography and in the life sciences.



A phase 1 study to address the safety and efficacy of G-CSF for the mobilization of haematopoietic progenitor cells in active rheumatoid arthritis. British Journal of Rheumatology 36(SUPPL 1): 191

A phase 1 study to evaluate the safety or re-infusing CD34 cells expanded ex vivo as part or all a PBPC transplant procedure. Blood 86(10 SUPPL 1): 294A

A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria. Vaccine 26(52): 6864-6873

A phase 1 trial of epirubicin and paclitaxel in patients with metastatic breast cancer. European Journal of Cancer 32A(SUPPL 1): S24

A phase 1 vaccine trial with recombinant parvovirus B19 virus-like particles in seronegative healthy adult volunteers. Blood 86(10 SUPPL 1): 135A

A phase 1-2 trial of DES plus low dose coumadin in advanced prostate cancer. Journal of Urology 155(5 SUPPL ): 610A

A phase 1/2 open-label study to determine the efficacy tolerability, and safety of the multidrug resistance modulator PSC 833 in combination with vinblastine in patients with advanced renal cell cancer. Blood 92(10 SUPPL 1 PART 1-2): 192B, Nov 15

A phase 1B trial of humanized monoclonal antibody M195 in myeloid leukemia Specific targeting without immunogenicity. Blood 82(10 SUPPL 1): 329A

A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas. Investigational New Drugs 26(4): 369-379

A phase 2 open study determining the efficacy and tolerance of casodex in patients with advanced prostate cancer. Urological Research 20(6): 452

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy. Haematologica 93(3): 405-412

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel. Cancer 112(3): 521-526

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Cancer 112(8): 1772-1779

A phase 2 survival comparison of patients with pancreatic cancer tpc treated with 5 fluorouracil f and calcium leucovorin l compared to matched tumor registry controls cpc. Clinical & Investigative Medicine 15(4 SUPPL): A89

A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha 2A in children with recurrent neuroblastoma or Wilms tumor A pediatric oncology branch, NCI and childrens oncology group study. Pediatric Blood and Cancer 49(5): 661-665

A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis. Journal of Acquired Immune Deficiency Syndromes 48(3): 304-309

A phase 3 trial comparing dodecafluoropentane and sonicated albumin in patients with suboptimal echoes. Circulation 94(8 SUPPL ): I575

A phase I HIV-1 vaccine trial in asymptomatic HIV-infected individuals using ENV 2-3 in MF-59 with or without MTP-PE. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 494

A phase I and immunologic study of bryostatin 1 in patients with solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 166

A phase I and pharmacodynamic study of sequential topotecan and etoposide in adult patients with refractory/relapsed acute leukemia. Blood 92(10 SUPPL 1 PART 1-2): 234A, Nov 15

A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer. Cancer ChemoTherapy and Pharmacology 61(4): 579-585

A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia. Investigational New Drugs 26(4): 331-338

A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period. Cancer Chemotherapy and Pharmacology 61(3): 515-524

A phase I and translational study of topotecanetoposide combination in relapsed or refractory non-Hodgkins lymphoma. Blood 92(10 SUPPL 1 PART 1-2): 237B, Nov 15

A phase I biomarker correlation study of taxol and endobronchial brachytherapy for non-small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 166

A phase I clinical study of the novel antifolate AG337 given by 5 day oral administration. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 178

A phase I clinical study of the novel antifolate AG337 given by a 5 day continuous infusion. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 240

A phase I clinical study with a rat anti-EGFR antibody in cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 426

A phase I clinical trial for patients with metastatic melanoma using autologous IL2 secreting melanoma as a vaccine. Cancer Gene Therapy 4(6 CONF SUPPL ): S48, Nov -Dec

A phase I clinical trial in cancer patients with a new monoclonal antibody , FC-215. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 219

A phase I clinical trial of HIV antigen pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. Journal of Allergy & Clinical Immunology 99(1 PART 2): S107

A phase I clinical trial of adenoviral-mediated herpes simplex Virus thymidine kinase gene therapy for malignant mesothelioma Preliminary results. Cancer Gene Therapy 3(6 CONF SUPPL ): S29

A phase I clinical trial of benzylacyclouridine as a biochemical modulator of 5-fluorouracil. Proceedings of the American Association for Cancer Research Annual Meeting 39: 321, March

A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2. Journal of the National Cancer Institute 87(2): 134-136

A phase I clinical trial of interferon infusion. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 414

A phase I clinical trial of low molecular weight heparin in patients with advanced AIDS. Blood 86(10 SUPPL 1): 931A

A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma. Cancer Chemotherapy and Pharmacology 61(6): 1069-1073

A phase I clinical trial of the DAT ligand I-123 altropane. Journal of Nuclear Medicine 39(5 SUPPL ): 239P, May

A phase I clinical trial with ONYX-015 administered by intratumoral injection in patients with recurrent head and neck carcinoma. Cancer Gene Therapy 4(6 CONF SUPPL ): S13, Nov -Dec

A phase I cohort study of suramin in patients with advanced cancer. Clinical Research 40(3): 738A

A phase I dose escalation of hydroxyurea in addition to continuous infusion 5-fluorouracil in patients with advanced colorectal cancer. European Journal of Cancer 34(SUPPL 2): S14, May

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor I EGFR and 2 HER2 tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours. British Journal of Cancer 98(1): 80-85

A phase I dose finding study of Docetaxel in combination with Vinorelbine An evaluation of the neurotoxicity in metastatic breast cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 168

A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer. Oncology 72(5-6): 322-325

A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. International Journal of Radiation Oncology, Biology, Physics 70(4): 993-1001

A phase I dose-escalation study of polyclonal CD4 T cell ex vivo expansion for immune system restoration of HIV infection. Journal of Allergy & Clinical Immunology 99(1 PART 2): S399

A phase I dose-finding study of PSC 833, a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor prognosis acute leukemia. Blood 90(10 SUPPL 1 PART 1): 566A, Nov 15

A phase I dose-finding study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia using mitoxantrone , etoposide , and the MDR modulator PSC833 Southwest Oncology Group Study No 9617. Blood 92(10 SUPPL 1 PART 1-2): 231A, Nov 15

A phase I dose-ranging trial of HGP-30 candidate vaccine in HIV sero-negative adults. Journal of Cellular Biochemistry Supplement 0(17 PART E): 76

A phase I gene therapy clinical study of autologous CD34+ cells transduced with an anti-HIV-1 ribozyme. Blood 92(10 SUPPL 1 PART 1-2): 665A, Nov 15

A phase I gene therapy clinical trial for the treatment of amyotrophic lateral sclerosis. Gene Therapy 2(SUPPL 1): S16

A phase I gene transfer clinical trial of an HIV-1 immunotherapeutic based on autologous fibroblasts transduced with a retroviral vector encoding HIV-1 ENV. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD [Author] Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 47

A phase I multi-dose trial of CD4 Pseudomonas exotoxin in HIV-1-infected individuals. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 478

A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer. Human Gene Therapy 9(12): 1775-1798

A phase I pharmacokinetic evaluation of high-dose thiotepa with marrow transplantation. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 395

A phase I pharmacokinetic study of IV heparinase I given to heparinized healthy men. Clinical Pharmacology & Therapeutics 63(2): 163, Feb

A phase I pharmacokinetics study of concomitant CPT-11 and 5FU combination. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 168

A phase I pilot study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in patients with locally advanced malignancies. International Journal of Radiation Oncology Biology Physics 24(SUPPL 1): 170

A phase I study of 1,2-diamminomethylcyclobutaneplatinum lactate administered daily for 5 days. British Journal of Cancer 67(2): 369-401

A phase I study of 2-chlorodeoxyadenosine in solid tumors. Clinical Pharmacology & Therapeutics 53(2): 232

A phase I study of AAV-CFTR administration in adult cystic fibrosis patients. Pediatric Research 41(4 PART 2): 301A

A phase I study of AN-9 , a lipophilic butyric acid analog, in patients with advanced solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 39: 507, March

A phase I study of CT-2584 in the treatment of advanced carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 39: 323, March

A phase I study of HD37-deglycosylated ricin A chain. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 252

A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Research & Human Retroviruses 8(8): 1321-1325

A phase I study of Targretin, an RXR-selective retinoid agonist. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 165

A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gynecologic Oncology 70(3): 404-409

A phase I study of a novel alkylating agent , adozelesin , in patients with refractory hematologic malignancies. Blood 86(10 SUPPL 1): 782A

A phase I study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 330

A phase I study of accelerated high dose epirubicin and cisplatin with G-CSF support in patients with advanced non small cell lung cancer. European Journal of Cancer 34(SUPPL 2): S31, May

A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study. Seminars in Oncology 22(4 Suppl 9): 2-6

A phase I study of chemoradiotherapy with cisplatin and navelbine for advanced malignancies of the chest. Clinical Research 42(3): 378A

A phase I study of chimeric anti-CD-4 monoclonal antibody in multiple sclerosis. Australian & New Zealand Journal of Medicine 22(4): 432

A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer. Seminars in Oncology 24(4 Suppl 12): S12-144-S12-148

A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study. Seminars in Oncology 22(5 Suppl 12): 54-8; Discussion 59-60

A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide GOFT in metastatic/locally advanced pancreatic carcinoma patients. Hepato Gastroenterology 54(79): 2141-2145

A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method. Japanese Journal of Clinical Oncology 37(12): 924-929

A phase I study of combined 2-chlorodeoxy-adenosine and chlorambucil in chronic lymphoid leukemia and low grade lymphoma. Blood 82(10 SUPPL 1): 580A

A phase I study of cyclophosphamide , VP-16, carboplatin , and total body irradiation with autologous stem cell transplantation for hematologic tumors. Journal of Cellular Biochemistry Supplement 0(18B): 83

A phase I study of cyclosporin A with Ara-C, mitoxantrone, etoposide in relapsed AML. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 225

A phase I study of docetaxel and bexarotene. ChemoTherapy 54(2): 125-130

A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers. Cancer ChemoTherapy and Pharmacology 62(2): 243-251

A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. RadioTherapy and Oncology 85(1): 36-41

A phase I study of dose-intensified PROMACECYTABOM with prophylactic granulocyte colony stimulating factor for patients with non-Hodgkins lymphoma. Blood 88(10 SUPPL 1 PART 1-2): 569A

A phase I study of etanidazole and radiotherapy in malignant glioma. International Journal of Radiation Oncology, Biology, Physics 29(3): 617-620

A phase I study of etoposide phosphate plus paclitaxel. Seminars in Oncology 23(6 Suppl 13): 30-33

A phase I study of fostriecin in a daily X 5 schedule. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 239

A phase I study of gemcitabine and carboplatin in non-small cell lung cancer. Seminars in Oncology 23(5 Suppl 10): 55-59

A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecologic Oncology 107(2): 274-279

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors. Investigational New Drugs 16(4): 325-330

A phase I study of gene therapy with recombinant intraperitoneal p53 in recurrent ovarian cancer. Cancer Gene Therapy 5(6 CONF SUPPL ): S25-S26, Nov -Dec

A phase I study of gossypol in HIV-infected patients in Mexico. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 245

A phase I study of high dose etoposide phosphate 2 hour infusion days 1 and 2. Blood 84(10 SUPPL 1): 708A

A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma. Human Gene Therapy 9(3): 379-390

A phase I study of idarubicin hydrochloride in patients with acute leukemia. Seminars in Hematology 33(4 SUPPL 3): 2-11

A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Seminars in Oncology 22(4 Suppl 9): 70-74

A phase I study of induction chemotherapy for older patients with acute myeloid leukemia using ara-C , daunorubicin and etoposide with and without the MDR modulator PSC-833 Cancer and leukemia group B study 9420. Blood 90(10 SUPPL 1 PART 1): 506A, Nov 15

A phase I study of interstitial ferromagnetic implants for the treatment of advanced and/or recurrent extracranial tumors. International Journal of Radiation Oncology Biology Physics 24(SUPPL 1): 296

A phase I study of intoplicine administered on a daily x 5 schedule. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 231

A phase I study of intrathecal topotecan. Proceedings of the American Association for Cancer Research Annual Meeting 39: 322, March

A phase I study of letrazuril in AIDS related cryptosporidiosis. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 56

A phase I study of mitoxantrone + VP-16 with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia. Blood 86(10 SUPPL 1): 514A

A phase I study of myeloid progenitor inhibitory factor-1 , a novel human beta; chemokine, in normal volunteers. Blood 92(10 SUPPL 1 PART 1-2): 380A, Nov 15

A phase I study of new drug Alnorin in patients with head and neck cancer treatment. European Cytokine Network 7(2): 310

A phase I study of oral uracil/ftorafur plus leucovorin and oral JM-216 each given over 14 days every 28 days Preliminary results. Journal of Investigative Medicine 45(7): 346A

A phase I study of paclitaxel as a radiation sensitizer for the treatment of non-small cell lung cancer and mesothelioma. International Journal of Radiation Oncology Biology Physics 32(SUPPL 1): 279

A phase I study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study. Beuzard, Y [Editor], Lubin, B [Editor], Rosa, J [Editor] [INSERM Colloquium; Sickle cell disease and thalassaemias: New trends in therapy] Colloque INSERM; Sickle cell disease and thalassaemias: New trends in therapy 301-302

A phase I study of pyrazoloacridine and carboplatin in patients with advanced solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 39: 323, March

A phase I study of rGP120w61D with SBAS1 and SBAS2 compared with alum in HIV negative volunteers Adverse events. AIDS (London) 12(SUPPL 4): S102, Nov

A phase I study of safety and efficacy for infusible platelet membrane in patients. Blood 86(10 SUPPL 1): 610A

A phase I study of somatuline in patients with metastatic androgen-resistant prostate cancer. Clinical Pharmacology & Therapeutics 55(2): 190

A phase I study of suramin in patients with advanced cancer. Clinical Pharmacology & Therapeutics 55(2): 190

A phase I study of sustained-duration filgrastim in normal volunteers. Experimental Hematology (Charlottesville) 26(8): 709, Aug

A phase I study of taxotere in pediatric patients. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 211

A phase I study of tecogalan, a novel angiogenesis inhibitor in the treatment of AIDS-related Kaposis sarcoma and solid tumors. Blood 84(10 SUPPL 1): 248A

A phase I study of the antipurine antifolate lometrexol administered with an oral folic acid supplement. British Journal of Clinical Pharmacology 37(5): 498P

A phase I study of the combination of docetaxel and doxorubicin in 1st line CT treatment of metastatic breast cancer Preliminary results. Breast Cancer Research & Treatment 37(SUPPL ): 91

A phase I study of the matrix metalloproteinase inhibitor AG3340 given in single doses to healthy volunteers. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 221

A phase I study of the novel antifolate 3,4-dihydro-2-amino-6-methyl-4-oxo-5 - quinazolone dihydrochloride given by a 24 intravenous continuous infusion. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 306

A phase I study of the safety of the nutritional supplement, Active Hexose Correlated Compound, AHCC, in healthy volunteers. Journal of Nutritional Science and Vitaminology 53(6): 536-539

A phase I study of topotecan plus cranial radiation for glioblastoma multiforme A Report of Radiation Therapy Oncology Group Study 95-07. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 271

A phase I study of vaccination with autologous, lethally irradiated melanoma cells engineered to secrete human GM-CSF A progress report. FASEB Journal 11(9): A998

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology 133(5): 1414-1422

A phase I trial administering the angiogenesis inhibitor TNP-470 to patients with HIV-associated Kaposis sarcoma. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14(4): A19

A phase I trial administering the angioinhibin TNP-470 to patients with HIV-associated Kaposis Sarcoma. AIDS Research & Human Retroviruses 10(SUPPL 3): S103

A phase I trial evaluating the tolerability and pharmacokinetics of 1263W94 following single oral administration of escalating doses in normal healthy volunteers. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 168

A phase I trial of 131I-CD4-gamma-2 in HIV-1 infected patients. INFECTIOUS DISEASES SOCIETY OF AMERICA [Author], NATIONAL INSTITUTES OF HEALTH [Author], CENTERS FOR DISEASE CONTROL AND PREVENTION [Author] 3rd Conference on retroviruses and opportunistic infections : 117

A phase I trial of 3-hour infusions of paclitaxel with or without granulocyte colony-stimulating factor. Seminars in Oncology 21(5 SUPPL 8): 9-14

A phase I trial of 9-aminocamptothecin. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 245

A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer. Hepato-Gastroenterology 55(82-83): 407-411

A phase I trial of HIV protease inhibitor KNI-272 in patients with AIDS or symptomatic HIV infection. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol One One world: One hope : 77

A phase I trial of adaptively-controlled etoposide phosphate combined with targeted dosing of carboplatin in small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 178

A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization. Japanese Journal of Clinical Oncology 38(4): 268-274

A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells. Blood 92(10 SUPPL 1 PART 1-2): 646A, Nov 15

A phase I trial of avonex for patients with recurrent malignant gliomas. Neurology 48(3 SUPPL 2): A27

A phase I trial of busulfan, melphalan, and thiotepa followed by peripheral blood stem cell transplant in patients with refractory malignancies. Breast Cancer Research & Treatment 32(SUPPL ): 64

A phase I trial of continuous intravenous infusion of interleukin-1 beta followed by carboplatin and cyclophosphamide in patients with advanced malignancies. Blood 84(10 SUPPL 1): 581A

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Investigation 25(6): 435-444

A phase I trial of doxorubicin and VX-710. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 165

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with hepatic tumors. International Journal of Radiation Oncology Biology Physics 36(1 SUPPL ): 212

A phase I trial of high-dose lovastatin shows activity against malignant astrocytoma. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 226

A phase I trial of high-dose melphalan, mitoxantrone and carboplatin in patients with ovarian and breast cancer. Blood 86(10 SUPPL 1): 973A

A phase I trial of humanized anti-TAC for the prevention of rejection in renal transplant recipients. Nephrology Dialysis Transplantation 10(6): 1059

A phase I trial of infusional vinblastine with cyclosporine analog, PSC 833 in patients with metastatic cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 166

A phase I trial of interleukin 3 pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplantation 16(5): 655-661

A phase I trial of liposomal daunorubicin administered with high-dose cytarabine to patients with relapsed acute leukemia. Blood 92(10 SUPPL 1 PART 1-2): 233A, Nov 15

A phase I trial of oral procysteine in early HIV infection. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 498

A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies. Seminars in Oncology 22(3 Suppl 6): 128-131

A phase I trial of r-metHuG-CSF as an adjunct to escalating doses of mitoxantrone in combination chemotherapy with cyclophosphamide and 5-fluorouracil in metastatic breast cancer. Breast Cancer Research & Treatment 23(1-2): 166

A phase I trial of recombinant human interleukin-6 in patients with thrombocytopenia. Blood 86(10 SUPPL 1): 686A

A phase I trial of sequential CAI and paclitaxel. Proceedings of the American Association for Cancer Research Annual Meeting 39: 323, March

A phase I trial of sequential topotecan and etoposide in adult acute myeloid leukemia. Blood 88(10 SUPPL 1 PART 1-2): 220A

A phase I trial of subcutaneous BB-10010 in breast cancer patients receiving high-dose cyclophosphamide. Experimental Hematology (Charlottesville) 24(9): 1104

A phase I trial of subcutaneous interleukin 1-alpha. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 464

A phase I trial of tumor necrosis factor and granulocyte-macrophage colony stimulating factor to enhance dendritic cell maturation. Journal of Cellular Biochemistry Supplement 0(21A): 11

A phase I trial of tumor necrosis factor receptor fusion protein in patients with advanced heart failure. Circulation 96(8 SUPPL ): I323, 10/21/97

A phase I trial of vesnarinone in HIV-infected persons with CD4+ cells counts greater than 200 cells/mu-l. INFECTIOUS DISEASES SOCIETY OF AMERICA [Author], NATIONAL INSTITUTES OF HEALTH [Author], CENTERS FOR DISEASE CONTROL AND PREVENTION [Author] 3rd Conference on retroviruses and opportunistic infections : 78

A phase I trial to assess the value of G-CSF in accelerating the dose rate of chemotherapy for intermediate and high grade non-Hodgkins lymphoma. British Journal of Haematology 86(SUPPL 1): 24

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkins Lymphoma. Hematological Oncology 14(4): 193-201

A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancer. Seminars in Oncology 24(1 Suppl 2): S2-23-S2-25

A phase I, open-label, single-dose study of blood and blister fluid pharmacokinetics of quinupristin/dalfopristin. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 24

A phase I, pharmacokinetic/pharmacodynamic study of dolastatin-10 in adult patients with advanced solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 306-307

A phase I, pharmacokinetic/pharmacodynamic study of the lipophilic thymidylate synthase inhibitor Thymitaq-TM administered orally, 6 hourly for 10 days. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 184

A phase I, placebo-controlled safety and immunogenicity trial of Genentech MN rgp120 HIV-1 vaccine in HIV-infected pregnant women with CD4 greater than 400. INFECTIOUS DISEASES SOCIETY OF AMERICA [Author], NATIONAL INSTITUTES OF HEALTH [Author], CENTERS FOR DISEASE CONTROL AND PREVENTION [Author] 3rd Conference on retroviruses and opportunistic infections : 98

A phase I, single-blind study to determine the safety, tolerance, pharmacokinetics and pharmacodynamics of anti-IgE recombination humanized monoclonal antibody E25 in adolescents and children with moderate to severe allergic asthma. Pediatric Research 39(4 PART 2): 9A

A phase I, single-dose evaluation of ALX40-4C in HIV-positive patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35(0): 24

A phase I-II clinical study of nystatin-LF IV in patients with HIV infections. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 483

A phase I-II dose ranging study of the safety and activity of Ro 31-8959 in asymptomatic or mildly symptomatic HIV-infection. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 474

A phase I-II dose ranging study of the safety and activity of in previously Zidovudine treated HIV-infected individuals. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 68

A phase I-II study of N- -L-aspartic acid added to 5-fluorouracil and folinic acid in advanced colorectal cancer. European Journal of Cancer 30A(7): 950-954

A phase I-II study of accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck. Clinical & Investigative Medicine (SUPPL ): S98

A phase I-II study of bi-weekly docetaxel combined with radiation therapy for patients with cancer of the larynx/hypopharynx. Japanese Journal of Clinical Oncology 37(9): 641-646

A phase I-II study of cyclophosphamide , VP-16, carboplatin , and total body irradiation with autologous stem cell transplantation for acute leukemia. Blood 88(10 SUPPL 1 PART 1-2): 244B

A phase I-II study of docetaxel plus cyclophosphamide as first line chemotherapy in metastatic breast cancer. Breast Cancer Research & Treatment 46(1): 60, Oct

A phase I-II study of ifosfamide and mitoxantrone for treatment and peripheral blood progenitor cell mobilization in multiple myeloma patients. Annals of Hematology 73(SUPPL 2): A142

A phase I-II study of infusional idarubicin, cyclophosphamide, and etoposide for the treatment of resistant multiple myeloma. Blood 86(10 SUPPL 1): 842A

A phase I-II trail of cisplatin , 5 fluorouracil , leucovorin, , and navelbine in advanced nonsmall cell lung cancer. Clinical Research 41(3): 704A

A phase I-II trial of escalating doses of ifosfamide in conjunction with standard dose doxorubicin and G-CSF in stage IV breast cancer. Breast Cancer Research & Treatment 23(1-2): 164

A phase I-II trial of granisetron for prevention of nausea and vomiting in patients receiving high-dose cyclophosphamide regimens followed by stem cell transplantation. Blood 88(10 SUPPL 1 PART 1-2): 415A

A phase I/II dose escalation trial of -1- propylcytosine. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 54

A phase I/II dose ranging study of DUROSTM implantable therapeutic system in patients with advanced prostate cancer. Journal of Urology 159(5 SUPPL ): 335, May

A phase I/II open-label study to assess the safety, pharmacokinetic profile, and preliminary antiviral effects of OST-577 administered to patients who are persistently hepatitis B antigen seropositive. Antiviral Research 23(SUPPL 1): 81

A phase I/II study of 3TC in children with HIV infection. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 478

A phase I/II study of 5-FU , leucovorin , and cisplatin with or without adriamycin in advanced cancer. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 200

A phase I/II study of PIXY321 for HIV related pancytopenia. Blood 86(10 SUPPL 1): 930A

A phase I/II study of SDZ PSC 833 in combination with daunorubicin and cytarabine in refractory acute myelogenous leukemia. Blood 88(10 SUPPL 1 PART 1-2): 216A

A phase I/II study of a novel nucleoside reverse transcriptase inhibitor, 1592U89 monotherapy vs 1592U89 + zidovudine in placebo in HIV infected patients with CD4 counts 200-500/mm-3. INFECTIOUS DISEASES SOCIETY OF AMERICA , NATIONAL INSTITUTES OF HEALTH , CENTERS FOR DISEASE CONTROL AND PREVENTION 3rd Conference on retroviruses and opportunistic infections : 89

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma. Cancer 73(11): 2803-2807

A phase I/II study of ampligen for the treatment of chronic hepatitis B. Hepatology 18(4 PART 2): 247A

A phase I/II study of arcon in locally advanced head and neck disease. British Journal of Cancer 74(SUPPL 28): 20

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115(8): 1398-404, 1404.E1

A phase I/II study of external beam radiatin, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus Preliminary toxicity report. International Journal of Radiation Oncology Biology Physics 32(SUPPL 1): 160

A phase I/II study of fractionated intensity modulated radiation therapy in the treatment of patients with primary or recurrent high grade gliomas. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 269

A phase I/II study of granulocyte-colony stimulating factor elicited white blood cell transfusions for neutropenia-related fungal infections. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 44

A phase I/II study of high-dose cytarabine and topotecan for the treatment of resistant acute myelogenous leukemia. Blood 92(10 SUPPL 1 PART 1-2): 218B, Nov 15

A phase I/II study of interleukin-2 to enhance the antileukemia effect of alpha-interferon in the treatment of chronic phase-chronic myeloid leukemia. Blood 88(10 SUPPL 1 PART 1-2): 576A

A phase I/II study of multicycle high-dose chemotherapy supported by filgrastim-mobilized peripheral blood progenitor cells for patients with advanced or high-risk cancer. Blood 92(10 SUPPL 1 PART 1-2): 369B, Nov 15

A Phase I/II study of paclitaxel and doxorubicin in the treatment of advanced breast cancer. Seminars in Oncology 23(1 Suppl 1): 19-23

A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. Seminars in Oncology 22(6 Suppl 15): 50-54

A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis. Blood 84(10 SUPPL 1): 413A

A phase I/II study of recombinant human interleukin 3 and granulocyte-macrophage colony stimulating factor fusion protein PIXY321 in patients with congenital amegakaryocytic thrombocytopenia. Blood 82(10 SUPPL 1): 608A

A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. Seminars in Oncology 23(5 Suppl 11): 16-22

A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Human Gene Therapy 9(6): 889-909

A phase I/II study of the protease inhibitor ritonavir in children with HIV infection. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol Two One world: One hope : 31

A phase I/II study of the safety of autologous gene modified T lymphocytes in patients with metastatic renal cancer. FASEB Journal 12(4): A288, March 17

A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous bone metastases-RTOG 88-22. International Journal of Radiation Oncology Biology Physics 32(SUPPL 1): 167

A phase I/II study to evaluate the safety, immunogenicity, pharmacokinetics and potential efficacy of IV rHu TNF binding protein pegylated dimer in patients with active RA. Arthritis & Rheumatism 41(9 SUPPL ): S58, Sept

A phase I/II study to evaluate the safety, immunogenicity, pharmacokinetics and potential efficacy of intravenous recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active rheumatoid arthritis. Journal of Interferon & Cytokine Research 18(5): A123, May

A phase I/II trial evaluating the combination use of recombinant GP160 and P24 vaccines in HIV-seropositive individuals regardless of initial CD4-positive cell counts. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 490

A phase I/II trial evaluating the combination use of recombinant GP160 and P24 vaccines vs GP160 and placebo by intradermal injection in HIV seropositive individuals regardless of initial CD4-positive cell counts. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 490

A phase I/II trial of BNCT for glioblastoma multiforme using intravenous boronophenylalanine-fructose complex and epithermal neutrons Early clinical results. Larsson, B , Crawford, J , Weinreich, R International Congress Series; Advances in Neutron capture therapy, Vol 1 Medicine and physics 56-59

A phase I/II trial of MNRGP 120 HIV-1 vaccine among injecting drug users in Bangkok, Thailand Safety and immunogenicity. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol Two One world: One hope : 41

A phase I/II trial of arsenic trioxide for relapsed and refractory acute promyelocytic leukemia. Blood 92(10 SUPPL 1 PART 1-2): 219B, Nov 15

A phase I/II trial of chemoembolization with mitomycin C following hepatic arterial fluorodeoxyuridine/leucovorin and whole liver radiotherapy for patients with intrahepatic malignancies. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 169

A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study. Seminars in Oncology 22(6 Suppl 15): 34-37

A phase I/II trial of combined immunoconjugate and chemotherapy for AIDS-related lymphoma. Blood 82(10 SUPPL 1): 386A

A phase I/II trial of high-dose etoposide , carboplatin and melphalan conditioning regimen for autologous bone marrow transplantation in stage IV breast cancer. Journal of Cellular Biochemistry Supplement 0(18B): 95

A phase I/II trial of increasing doses of mitoxantrone with fludarabine and cytarabine in relapsed acute leukemia and chronic myelogenous leukemia in blastic phase. Blood 90(10 SUPPL 1 PART 2): 243B, Nov 15

A phase I/II trial of the ACT CD34+ enrichment kit to enrich mobilized peripheral blood progenitor cells for breast cancer patients receiving myeloablative chemotherapy. Blood 88(10 SUPPL 1 PART 1-2): 110A

A phase I/II trial of total marrow irradiation, busulfan and cyclophosphamide followed by peripheral autologous PBSCT in patients with advanced multiple myeloma. Experimental Hematology (Charlottesville) 25(8): 851

A phase I/II trial of total marrow irradiation, busulfan and cyclophosphamide followed by peripheral blood stem cell transplantation in patients with advanced multiple myeloma. Blood 88(10 SUPPL 1 PART 1-2): 132A

A phase I/II trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 155

A phase I/pharmacokinetic study of 5-ethynyluracil plus 5-fluorouracil in cancer patients with solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 241

A phase I/phase II study of high dose vitamin K to patients with advanced, inoperable hepatocellular carcinoma interim analysis. Hepatology 20(4 PART 2): 278A

A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine Study design and goals. Seminars in Oncology 22(2 SUPPL 5): 38-40

A phase IB trial of murine monoclonal R-24 in metastatic melanoma. Journal of Investigative Dermatology 100(4): 576

A phase IB/II multi-dose trial of gadolinium-texaphyrin as a radiosensitizer in patients with brain metastases treated with conventional radiation therapy Preliminary results. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 270

A phase II HIV prophylactic vaccine trial in seronegative volunteers Expanded safety and immunogenicity evaluation of two recombinant gp120 vaccines. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 238

A phase II HIV vaccine trial in seronegative subjects Safety, immunogenicity, and future directions. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 91

A phase II HIV vaccine trial in seronegative volunteers Expanded safety and immunogenicity evaluation of two recombinant GP120 vaccines. Journal of Cellular Biochemistry Supplement 0(18B): 158

A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168). Investigational New Drugs 26(3): 265-272

A phase II and pharmacologic study of Taxol by weekly one-hour infusion in the treatment of patients with metastatic breast cancer. Breast Cancer Research & Treatment 41(3): 234

A phase II chemoprevention trial design to identify surrogate endpoint biomarkers in breast cancer. Journal of Cellular Biochemistry. Supplement 23: 19-24

A phase II clinical trial bisantrene, VP-16 and carboplatin in refractory and relapsed acute leukemia of childhood. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 232

A phase II clinical trial of daunoxome in Kaposis sarcoma of AIDS patients. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 58

A phase II clinical trial of etoposide, intermediate-dose cytarabine and carboplatin in refractory acute myeloid leukemia and blast crisis of chronic myeloid leukemia. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 198

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. British Journal of Haematology 140(4): 385-393

A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors. Journal of Veterinary Internal Medicine 22(2): 388-393

A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia. Seminars in Hematology 33(4 Suppl 3): 12-17

A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. British Journal of Dermatology 159(1): 205-210

A phase II dose-ranging trial of single-agent pamidronate for relapsed/refractory multiple myeloma. Blood 92(10 SUPPL 1 PART 1-2): 107A, Nov 15

A phase II evaluation of L-phenylalanine mustard and cisplatin patients with stage III and IV epithelial ovarian carcinoma. Gynecologic Oncology 49(1): 135-136

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission. Cancer 110(11): 2448-2456

A phase II investigation of pentostatin in metastatic malignant melanoma. Investigational New Drugs 10(4): 345-346

A phase II multi-centre study of sequential response-adapted induction regimens idarubicin/cytarabine and mitoxantrone/etoposide, for treatment of de novo AML. Clinical & Investigative Medicine 18(4 SUPPL ): B62

A phase II multi-institutional study of estra-1,3,5 -triene-3,17-beta-diol, 3-benzoate, 17 aminophenyl-1-oxobutoxyacetate. Anticancer Research 13(6B): 2361-2365

A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study. Oncology Reports 19(6): 1551-1556

A phase II multicenter trial of photodynamic therapy as treatment for refractory carcinoma in situ. Journal of Urology 149(4 SUPPL ): 281A

A phase II of cisplatin , ifosfamide and increasing dosage of navelbine in unresectable non-small cell lung cancer. British Journal of Cancer 76(SUPPL 1): 53

A phase II open label combination study of the tolerability and activity of ddC and interferon alpha in patients with early symptomatic HIV-infection. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD [Author] Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 211

A phase II open-label, randomized study of the triple combination of Indinavir, zidovudine and didanosine versus Indinavir alone and zidovudine/didanosine in antiretroviral naive patients. INFECTIOUS DISEASES SOCIETY OF AMERICA [Author], NATIONAL INSTITUTES OF HEALTH [Author], CENTERS FOR DISEASE CONTROL AND PREVENTION [Author] 3rd Conference on retroviruses and opportunistic infections : 90

A phase II pilot study for the treatment of HCV RNA positive blood donors with minimal or mild chronic hepatitis. Hepatology 28(4 PART 2): 211A, Oct

A phase II prospective study of concomitant radiotherapy and chemotherapy for locally advanced carcinoma of the prostate. Journal of Urology 149(4 SUPPL ): 258A

A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis. British Journal of Cancer 98(4): 720-727

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114(10): 1860-1867

A phase II randomized controlled trial of Synsorb-Pk for the prevention of hemolytic uremic syndrome in children with verotoxin-producing E coli gastroenteritis. Pediatric Research 41(4 PART 2): 283A

A phase II randomized trial of 13-cis retinoic acid and interferon alfa-2A in the treatment of plexiform neurofibroma in patients with neurofibromatosis type I. Pediatric Research 37(4 PART 2): 151A

A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer. Seminars in Oncology 24(4 Suppl 12): S12-130-S12-134

A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer. British Journal of Cancer 98(1): 22-24

A phase II study of *Stealth liposomal doxorubicin hydrochloric acid in HIV-associated Kaposis sarcoma. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 397

A phase II study of 13-cis retinoic acid in juvenile myelomonocytic leukemia A Pediatric Oncology Group study. Blood 90(10 SUPPL 1 PART 1): 346A, Nov 15

A phase II study of 5-aza-2-deoxycytidine in hormone independent metastatic prostate cancer. Tumori 84(1): 87-89, Jan -Feb

A phase II study of CI-973 -. Cancer Chemotherapy & Pharmacology 38(3): 289-291

A phase II study of CID therapy and early PBSCT in patients with de novo multiple myeloma. British Journal of Haematology 102(1): 352, July 1

A phase II study of CPT-11 in advanced breast cancer. International Journal of Oncology 5(SUPPL ): 404-405

A phase II study of D-verapamil plus doxorubicin in advanced colorectal cancer. Annals of Hematology 65(SUPPL ): A15

A phase II study of Didemnin B in advanced malignant melanoma An Eastern Cooperative Oncology Group study. Investigational New Drugs 16(3): 259-263, 1998-

A phase II study of a combined therapy with carboplatin and etoposide in patients with stage IV non small cell lung cancer. European Respiratory Journal Supplement 9(23): 306S

A phase II study of all-trans-retinoic acid in patients with metastatic melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 410

A phase II study of biochemotherapy in stage IV melanoma. Melanoma Research 7(SUPPL 1): S113-S114

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma. Cancer ChemoTherapy and Pharmacology 62(1): 77-84

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer. Cancer ChemoTherapy and Pharmacology 62(5): 763-768

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. Gynecologic Oncology 110(2): 140-145

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine for advanced non-small cell lung cancer Rationale and study design. Seminars in Oncology 21(5 SUPPL 10): 79-84

A phase II study of continuous infusion recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to autologous bone marrow transplantation for non-Hodgkins lymphoma in first remission. Blood 82(10 SUPPL 1): 145A

A phase II study of continuous infusional 5-fluorouracil and subcutaneous interleukin-2 in metastatic renal cancer. European Journal of Cancer 33(7): 1149-1151

A phase II study of daily subcutaneous low dose interleukin-2 , in HIV-associated malignancies. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 17(4): A32, April 1

A phase II study of docetaxel and epirubicin in patients with advanced breast cancer. Anticancer Research 18(5C): 3872, Sept -Oct

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer ChemoTherapy and Pharmacology 61(4): 631-637

A phase II study of epirubicin in combination therapy of small cell lung cancer. European Journal of Cancer 32A(SUPPL 1): S8

A phase II study of epirubicin, cisplatin and prolonged venous infusional 5-FU in relapsed epithelial ovarian cancer. British Journal of Cancer 76(SUPPL 1): 29

A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer. European Journal of Cancer 29a(9): 1355-1355

A phase II study of filgrastim-mobilized peripheral blood progenitor cell infusion support for pediatric patients treated with ifosfamide, carboplatin and etoposide. Blood 86(10 SUPPL 1): 403A

A phase II study of filgrastim-mobilized peripheral blood progenitor cells infusion support for relapsed pediatric solid tumors being treated with ifosfamide, carboplatin and etoposide. Blood 90(10 SUPPL 1 PART 2): 321B, Nov 15

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer. Bju International 102(11): 1601-1606

A phase II study of high-dose epirubicin plus cyclophosphamide with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors A trial of the Japan Clinical Oncology Group. Japanese Journal of Clinical Oncology 27(5): 325-330, Oct

A phase II study of hirulog in the prevention of venous thrombosis after major hip or knee surgery. Circulation 86(4 SUPPL 1): I409

A phase II study of ifosfamide and Navelbine for advanced breast cancer. Breast Cancer Research & Treatment 41(3): 236

A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer. Seminars in Oncology 19(6 Suppl 12): 51-56

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer 50(2): 254-258

A phase II study of induction chemotherapy followed by concomitant chemoradiotherapy for nasopharyngeal cancer. Journal of Investigative Medicine 46(7): 255A, Sept

A phase II study of interferon alpha-2a and modulated 5-fluorouracil in patients with advanced neuroendocrine tumours. British Journal of Cancer 76(SUPPL 1): 49

A phase II study of interleukin-2 and alpha-2A-interferon in advanced sarcomas. Onkologie 15(SUPPL 1): 22

A phase II study of interleukin-2 in patients with myelodysplastic syndromes. Blood 90(10 SUPPL 1 PART 2): 289B, Nov 15

A phase II study of intermittent androgen suppression in men with a rising serum PSA after radiation for localized prostate cancer. Clinical & Investigative Medicine 20(4 SUPPL ): S58

A phase II study of intravenous gammalinolenic acid pre-treatment in patients with pancreatic or colorectal cancer treated with 5-fluorouracil. British Journal of Cancer 76(SUPPL 1): 47

A phase II study of iododoxorubicin in advanced non-small cell lung cancer. Annals of Hematology 65(SUPPL ): A138

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer. Cancer ChemoTherapy and Pharmacology 61(2): 275-281

A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. Investigational New Drugs 26(3): 249-255

A phase II study of liarozole fumarate A new P-450 retinoic acid hydroxylase inhibitor - in postmenopausal women with metastatic breast cancer. Breast Cancer Research & Treatment 41(3): 290

A phase II study of liarozole fumarate in postmenopausal women with metastatic breast cancer. Breast Cancer Research & Treatment 37(SUPPL ): 71

A phase II study of low dose interferon alpha maintenance in chronic myeloid leukemia. Blood 92(10 SUPPL 1 PART 1-2): 250B, Nov 15

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. Bju International 101(9): 1084-1089

A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer. Cancer ChemoTherapy and Pharmacology 61(3): 453-458

A phase II study of mitoxantrone alone during induction and intron-A during maintenance in low-grade non-Hodgkins lymphoma. British Journal of Haematology 93(SUPPL 2): 368

A phase II study of mitoxantrone, cyclophosphamide, and thiotepa with peripheral buffy coat support in patients with advanced breast cancer failing standard dose therapy. Breast Cancer Research & Treatment 23(1-2): 163

A phase II study of oral etoposide in AIDS-related Kaposis sarcoma. TENTH INTERNATIONAL CONFERENCE ON AIDS, INTERNATIONAL CONFERENCE ON STD Tenth International Conference on AIDS and the International Conference on STD, Vol 1; The global challenge of AIDS: Together for the future : 1) 173

A phase II study of oral etoposide in patients with metastatic breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 227

A phase II study of paclitaxel and doxorubicin as second-line treatment in recurrent ovarian cancer after cisplatin failure. Gynecologic Oncology 68(1): 123, Jan

A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group. Seminars in Oncology 22(3 Suppl 6): 75-77

A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer ChemoTherapy and Pharmacology 61(2): 315-321

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy. Cancer ChemoTherapy and Pharmacology 62(1): 59-64

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer. Breast Cancer Research and Treatment 110(2): 309-315

A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma. Investigational New Drugs 26(4): 381-386

A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck. European Journal of Cancer 30a(7): 1044-1045

A phase II study of placebo versus recombinant human macrophage colony-stimulating factor to augment antifungal therapy in patients with invasive candida or aspergillus fungal infection. Blood 82(10 SUPPL 1): 504A

A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma. Investigational New Drugs 16(4): 337-340

A phase II study of recombinant human granulocyte-colony stimulating factor in the treatment of granulocytosis in children. Nouvelle Revue Francaise d'Hematologie 36(6): 441-448

A phase II study of recombinant interferon-beta in combination with 5-fluorouracil in the treatment of patients with advanced colorectal carcinoma. British Journal of Cancer 75(3): 423-426

A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer. Seminars in Oncology 24(5 Suppl 17): S17-81-S17-86

A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial. Japanese Journal of Clinical Oncology 38(6): 432-437

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling. British Journal of Cancer 98(8): 1327-1335

A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience. Cancer Investigation 25(8): 733-737

A phase II study of single agent gemcitabine in patients with cisplatin-refractory or relapsed testicular germ cell tumors. Annals of Hematology 77(SUPPL 2): S178

A phase II study of subcutaneous IL-2 plus antiretrovirals vs ARV alone in patients with HIV infection and CD4+ cell count greater than or equal to 350/MM3. AIDS (London) 12(SUPPL 4): S65, Nov

A phase II study of subcutaneous interleukin-2 , alpha interferon and prolonged venous infusional 5-FU in patients with metastatic renal cell cancer. British Journal of Cancer 76(SUPPL 1): 50

A phase II study of subcutaneous rh-IL-2, rh-IFN-alfa-2a, and intravenous 5-fluorouracil in patients with advanced colorectal carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 218

A phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer Simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. Journal of Urology 157(4 SUPPL ): 334

A phase II study of tamoxifen and 4-HPR in women with metastatic breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 204

A phase II study of thalidomide for Kaposis sarcoma Activity and correlation with KSHV DNA load. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14(4): A35

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer 110(11): 2535-2541

A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Investigational New Drugs 26(1): 89-94

A phase II study of the oral matrix metalloproteinase inhibitor, marimastat, in patients with inoperable gastric cancer. Gastroenterology 114(4 PART 2): A688, April 15

A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Investigational New Drugs 13(4): 337-342

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial. Cancer ChemoTherapy and Pharmacology 61(3): 509-514

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology 109(2): 182-186

A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix. Gynecologic and Obstetric Investigation 64(4): 193-198

A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. RadioTherapy and Oncology 85(3): 429-434

A phase II study to assess efficacy and safety of interferon alpha 2b in combination with oral cytarabine ocfosfate in patients with chronic myelogenous leukemia. Blood 92(10 SUPPL 1 PART 1-2): 627A, Nov 15

A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients. Blood 92(10 SUPPL 1 PART 1-2): 632A, Nov 15

A phase II study with vinorelbine and epirubicin in metastatic breast cancer. Breast Cancer Research & Treatment 27(1-2): 146

A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy. Breast Cancer Research and Treatment 108(1): 79-85

A phase II trial of 13 cis retinoic acid for poor risk AIDS associated Kaposis sarcoma. AIDS (London) 10(SUPPL 2): S49

A phase II trial of 13-cis retinoic acid and interferon-alpha in UICC stage III/IV pancreatic cancer. Gastroenterology 114(4 PART 2): A569, April 15

A phase II trial of CPT-11 in chemotherapy-naive patients with recurrent squamous carcinoma of the cervix A Gynecologic Oncology Group study. Gynecologic Oncology 68(1): 101, Jan

A phase II trial of CPT-11 in patients with advanced gastric carcinoma. Annals of Hematology 77(SUPPL 2): S44

A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecologic Oncology 70(3): 334-338

A phase II trial of DMP-840 in 5-FU refractory advanced colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 170

A phase II trial of G-CSF with or without SDZ ILE 964 for the mobilization of peripheral blood progenitor cells for autologous progenitor cell transplantation. Blood 84(10 SUPPL 1): 106A

A phase II trial of Taxol in advanced and recurrent adenocarcinoma of the endometrium A Gynecologic Oncology Group Study. Gynecologic Oncology 56(1): 120

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer. Journal of Urology 178(6): 2378-83; Discussion 2383-4

A phase II trial of cisplatin and cyclophosphamide in the treatment of extraovarian peritoneal serous papillary carcinoma with comparison to papillary serous ovarian carcinoma A Gynecologic Oncology Group study. Gynecologic Oncology 68(1): 109, Jan

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102. Bju International 101(1): 20-25

A phase II trial of docetaxel Taxotere R as second-line chemotherapy in patients with metastatic breast cancer. Journal of Cancer Research and Clinical Oncology 134(2): 125-135

A phase II trial of docetaxel in patients with anthracycline resistant metastatic breast cancer. Breast Cancer Research & Treatment 37(SUPPL ): 89

A phase II trial of dose-intensive carboplatin-cisplatin and cyclophosphamide in unfavorable stage III and IV epithelial ovarian cancer. Gynecologic Oncology 49(1): 123

A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer. Investigational New Drugs 26(2): 183-188

A phase II trial of epirubicin plus paclitaxel in metastatic breast cancer. Seminars in Oncology 24(5 SUPPL 17): 44-47, Oct

A phase II trial of filgrastim support high dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for high risk Non-Hodgkins Lymphoma A multicenter pilot study. Blood 88(10 SUPPL 1 PART 1-2): 118A

A phase II trial of filgrastim supported high dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for high risk non-Hodgkins lymphoma A multicenter pilot study. Blood 86(10 SUPPL 1): 964A

A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer. Seminars in Oncology 24(3 Suppl 8): S8-36-S8-38

A phase II trial of high dose late intensification therapy in patients with chemotherapy sensitive multiple myeloma. Blood 90(10 SUPPL 1 PART 2): 408B, Nov 15

A phase II trial of high dose sequential chemotherapy and peripheral blood stem cell transplantation The impact of involved field radiation therapy. Blood 90(10 SUPPL 1 PART 2): 400B, Nov 15

A phase II trial of high dose toremifene in estrogen and progesterone receptor negative metastatic breast cancer. Breast Cancer Research & Treatment 23(1-2): 169

A phase II trial of ifosfamide and mesna in patients with previously treated ovarian sarcomas. Gynecologic Oncology 49(1): 125

A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer. Pancreas 36(4): 341-345

A phase II trial of irinotecan in hormone-refractory prostate cancer. Investigational New Drugs 16(4): 353-359

A phase II trial of mobilization of peripheral blood progenitor cells with docetaxel and filgrastim A companion study for patients with epithelial ovarian cancer and breast cancer eligible for high dose chemotherapy. Blood 92(10 SUPPL 1 PART 1-2): 270A, Nov 15

A phase II trial of murine MoAb D612 combined with recombinant human M-CSF in patients with metastatic gastrointestinal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 252

A phase II trial of oral VP-16 with mitoxantrone and ifosfamide/mesna for salvage of relapsed or refractory lymphoma. Blood 82(10 SUPPL 1): 576A

A phase II trial of outpatient subcutaneous GM-CSF, interleukin-2, and interferon-alpha plus oral cis-retinoic acid in patients with metastatic renal cell cancer. Journal of Investigative Medicine 46(7): 274A, Sept

A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience. Cancer Investigation 25(7): 599-605

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus. American Journal of Clinical Oncology 31(1): 29-33

A phase II trial of paclitaxel in advanced esophageal cancer Preliminary report. Seminars in Oncology 21(5 SUPPL 8): 44-48

A phase II trial of paclitaxel in patients with HIV-associated Kaposis Sarcoma. AIDS Research & Human Retroviruses 10(SUPPL 3): S103

A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies. Seminars in Oncology 22(3 Suppl 6): 41-46

A phase II trial of radiotherapy with concurrent tirapazamine, a hypoxic cytotoxin, for advanced head and neck carcinomas. International Journal of Radiation Oncology Biology Physics 36(1 SUPPL ): 202

A phase II trial of the use of docetaxel Vinorelbine in combination with GM-CSF in taxol refractory metastatic breast cancer. Breast Cancer Research & Treatment 46(1): 95, Oct

A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization. Cancer ChemoTherapy and Pharmacology 61(4): 683-688

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Gynecologic Oncology 108(1): 42-46

A phase II trial with D-trp-6 in premenopausal RH +, hormonal untreated advanced breast cancer patients. Breast Cancer Research & Treatment 28(1): 84

A phase II trial with an anti-CD25 ricin A-chain immunotoxin in patients with refractory Hodgkins lymphoma. Annals of Hematology 77(SUPPL 2): S91

A phase II trial with roxithromycin in AIDS-related cryptosporidium diarrhea. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol Two One world: One hope : 287

A phase II, double-blind, placebo-control, dose-ranging study to assess the antiretroviral activity and safety of efavirenz in combination with open-label zidovudine w/ lamivudine at48 weeks. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 441

A phase II, double-blind, placebo-controlled, dose ranging study to assess the antiretroviral activity and safety of efavirenz in combination with open-label zidovudine with lamivudine at 48 weeks. AIDS (London) 12(SUPPL 4): S35, Nov

A phase II, double-blind, placebo-controlled, multi-center study to determine the effectiveness and tolerability of the combination of efavirenz and indinavir versus IDV in HIV-1 infected patients receiving nucleoside analogue therapy at 36 weeks. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 441

A phase II, multi-center randomized, open label study to compare the antiretroviral activity and tolerability of efavirenz + indinavir , versus EFV + zidovudine +lamivudine , versus IDV + 3TC at 36 weeks. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 394

A phase II, open-label study to evaluate two different schedules for integrating Filgrastim as adjuvant therapy in the treatment of patients with Hodgkins lymphoma receiving MOPP/ABV hybrid chemotherapy. Blood 86(10 SUPPL 1): 52A

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy. Breast Cancer Research and Treatment 110(2): 327-335

A phase II/III randomized study of immediate versus deferred intravenous cidofovir for the treatment of peripheral CMV retinitis in patients with AIDS. AMERICAN SOCIETY FOR MICROBIOLOGY [Author] Human retroviruses and related infections : 170

A phase II/III randomized, double-blind, placebo-controlled multicenter trial of humanized anti-tac for prevention of acute graft-versus-host disease in recipients of marrow transplants from unrelated donors. Blood 86(10 SUPPL 1): 621A

A phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer A National Cancer Institute of Canada Study. Clinical & Investigative Medicine 19(4 SUPPL ): S61

A phase III pivotal trial of IDEC-C2B8 in patients with relapsed low-grade or follicular lymphoma. Journal of Molecular Medicine (Berlin) 75(7): B231

A phase III prospective, randomized, double-blind study of the safety and efficacy of clarithromycin vs rifabutin vs CLA+RBT for prevention of Mycobacterium avium complex disease in HIV+ patients with CD4 counts less than or equal to 100 cells/mu-L. INFECTIOUS DISEASES SOCIETY OF AMERICA , NATIONAL INSTITUTES OF HEALTH , CENTERS FOR DISEASE CONTROL AND PREVENTION 3rd Conference on retroviruses and opportunistic infections : 91

A phase III randomised placebo-controlled study in 315 pediatric and adult autologous or allogeneic bone marrow transplantation with Lenograstim 5 mu-g/kg/day. Blood 82(10 SUPPL 1): 455A

A phase III randomised study of carboplatin and amifostine vs carboplatin and G-Csf in patients with inoperable non-small cell lung cancer. Blood 88(10 SUPPL 1 PART 1-2): 350A

A phase III randomized prospective trial of external beam radiotherapy , mitomycin C , BCNU, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology Biology Physics 30(SUPPL 1): 214

A phase III randomized study comparing, in non metastatic unresectable non-small cell lung cancer responding to chemotherapy , further CT to loco-regional irradiation. European Respiratory Journal 12(SUPPL 28): 8S, Sept

A phase III randomized study of surgery vs surgery plus adjunctive radiation therapy in intermediate-risk endometrial adenocarcinoma. Gynecologic Oncology 68(1): 135, Jan

A phase III randomized trial comparing the efficacy and safety of the 3-monthly 108-mg depot of Zoladex with the monthly 36-mg depot in patients with advanced prostate cancer. European Urology 27(1): 43-46

A phase III randomized trial evaluating in patients with advanced non small cell lung cancer the addition of ifosfamide to a combination of cisplatin and carboplatin. European Respiratory Journal Supplement 10(25): 153S, Sept

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil versus cyclophosphamide, Adriamycin, and 5-fluorouracil in patients with metastatic breast cancer. Breast Cancer Research & Treatment 34(1): 15-24

A phase III study evaluating CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation for patients with advanced multiple myeloma Engraftment results. Blood 90(10 SUPPL 1 PART 1): 218A, Nov 15

A phase III study of Taxotere vs doxorubicin in patients with metastatic breast cancer who have failed an alkylating containing regimen. Breast Cancer Research & Treatment 46(1): 23, Oct

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). International Journal of Radiation Oncology, Biology, Physics 71(1): 79-86

A phase III study of daunorubicin vs idarubicin bvs mitoxanthrone for older adult patients with acute myelogenous leukemia A study of the Eastern Cooperative Oncology Group. Blood 92(10 SUPPL 1 PART 1-2): 313A, Nov 15

A phase III study of priming with yeast-derived granulocyte-macrophage colony-stimulating-factor for older adult patients with acute myelogenous leukemia A study of the Eastern Cooperative ONcology Group. Blood 92(10 SUPPL 1 PART 1-2): 679A, Nov 15

A phase III study of recombinant human growth hormone in patients with AIDS wasting. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS [Author] Eleventh International Conference on AIDS, Vol One One world: One hope : 26

A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 114(10): 1822-1830

A phase III trial comparing external-beam irradiation plus short-term maximal androgen blockade with radiation therapy alone for locally advanced prostate cancer. European Urology 26(SUPPL 1): 3, 1994 ( )

A phase III trial of ifosfamide alone or in combination with cisplatin in the treatment of advanced, persistent, or recurrent carcinosarcoma of the uterus A Gynecologic Oncology Group Study. Gynecologic Oncology 68(1): 137, Jan

A phase III trial of recombinant human erythropoietin therapy in non-anemic orthopaedic patients Dose, response, toxicity, and efficacy. Clinical Research 41(2): 199A

A phase III trial of subcutaneous administration of rhG-CSF in the myelodysplastic syndromes. Japanese Journal of Clinical Hematology 35(11): 1289-1296

A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. International Journal of Radiation Oncology, Biology, Physics 69(5): 1496-1501

A phase III, multicenter, randomized, open label study to compare the antiretroviral activity and tolerability of efavirenz plus indinavir , versus EFV plus zidovudine plus lamivudine , versus IDV plus ZDV plus 3TC at 36 weeks. AIDS (London) 12(SUPPL 4): S13, Nov

A phase III, multicenter, randomized, open-label study to compare the safety and tolerability of sevoflurane vs isoflurane administered with nitrous oxide and oxygen in ASA class I, II, and III patients. Anesthesiology (Hagerstown) 79(3A): A354

A phase III, randomized multicenter study of induction with or without granulocyte colony stimulating factor followed by intensive consolidation versus stem cell transplantation in AML. Blood 90(10 SUPPL 1 PART 2): 237B, Nov 15

A phase III, randomized, open-label study to compare sevoflurane and isoflurane in neurosurgical patients. Anesthesia & Analgesia 80(2 SUPPL ): S214

A phase Ib study to evaluate repeated daily intravenous doses of RSR13 administered to cancer patients receiving concurrent radiation therapy. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 330

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers. British Journal of Cancer 98(11): 1774-1780

A phase analysis of cardiac activity in patients with hypertensive disease treated with depressin. Vrach Delo 8: 24-28

A phase and electron microscopic study of cellular differentiation in pancreatic acinar cells of the mouse. American Journal of Anatomy 103(1): 1-33

A phase contrast microprecipitin test with poliovirus antigens. I. Properties of the antigens and antibodies and optimum conditions for reaction. Archiv für die Gesamte Virusforschung 11: 120-151

A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses. Archiv für die Gesamte Virusforschung 11: 152-175

A phase contrast microscopic study on the induction of cellular deformation in mast cells. Yonsei Medical Journal 7: 1-6

A phase contrast microscopy study of x-ray-induced pyknosis in the living cell. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 78(2): 597-602

A phase contrast study of the blood-cells of Prodenia larvae. Quart Jour Microsc Sci 100(1): 17-24

A phase contrast study of the chromatinic bodies of Escherichia coli subsequent to ultraviolet irradiation. Journal of Bacteriology 71(4): 462-473

A phase diagram for erythrocytes cryopreserved in hydroxyethyl starch solution. Cryobiology 32(6): 545

A phase fluorometric optical carbon dioxide gas sensor demonstrated in fermentation off-gas monitoring. Abstracts of Papers American Chemical Society 211(1-2): BIOT 197

A phase i and comparative pharmacologic study of standard and liposome encapsualted doxorubicin dox and lipodox. Proceedings of the American Association for Cancer Research Annual Meeting 32: 201

A phase i and ii study of the combination therapy of 4 o tetrahydropyranyldoxorubicin thp 5 fluorouracil 5 fu and high dose folinic acid hdfa in a weekly schedule in patients with advanced breast cancer. Onkologie 14(SUPPL 2): 137

A phase i and pharmacologic analysis of fluorouracil plus leucovorin combined with infused high dose zidovudine. Proceedings of the American Association for Cancer Research Annual Meeting 33: 427

A phase i b trial of anti cd3 mab plus il2 in patients with cancer. Proceedings of the American Association for Cancer Research Annual Meeting 32: 248

A phase i biological dose response study of rhg csf in newborns with presumed sepsis significant induction of peripheral neutrophilia. Clinical Research 40(1): 5A

A phase i clinical pharmacologic study of ci 973. Proceedings of the American Association for Cancer Research Annual Meeting 31: 181

A phase i clinical trial in cancer patients with two new monoclonal antibodies mabs fc 205 and fc 206. Proceedings of the American Association for Cancer Research Annual Meeting 33: 346

A phase i clinical trial of recombinant human interleukin 6 rhll 6 in solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 33: 232

A phase i clinical trial with chimeric anti cd4 monoclonal antibody in patients with mycosis fungoides. Journal of Cellular Biochemistry Supplement (14 PART B): 108

A phase i comparative study of the safety tolerance and pharmacokinetics pk of 14 and one half days of oral u 87201e in men versus women. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b88

A phase i dose intensity trial for node positive breast cancer patients using adjuvant cyclophosphamide c doxorubicin a and granulocyte colony stimulating factor gcsf. Proceedings of the American Association for Cancer Research Annual Meeting 33: 256

A phase i evaluation of 256u87 an acyclovir acv prodrug in hiv infected patients. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b238

A phase i ii clinical trial of intra arterial mitoxantrone nov chemotherapy in locally advanced recurrent breast cancer patients a preliminary report. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 404

A phase i ii dose ranging trial of oral dextran sulfate in hiv p24 antigen positive individuals actg 060 results of a safety and efficacy trials. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 404

A phase i ii evaluation of effervescent and enteric coated oral formulations of pamidronate. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 488

A phase i ii multicenter study of recombinant human tumor necrosis factor alpha in combination with recombinant human gamma interferon in patients with metastasizing renal cell carcinoma. Journal of Urology 143(4 SUPPL): 319A

A phase i ii open label trial to evaluate the antiviral potential of combination low dose zidovudine zdv and interferon alpha 2a ifn alpha in patients with symptomatic hiv disease. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 64b

A phase i ii study of 3tc gr109714x. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 204

A phase i ii study of 3tc in hiv positive asymptomatic or mild arc patients. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : we47

A phase i ii study of concomitant 5 fluorouracil 5 fu protracted infusion pi and radiotherapy in gastrointestinal tumors. International Journal of Radiation Oncology, Biology, Physics 19(SUPPL 1): 263

A phase i ii study of induction chemotherapy in advanced head and neck cancer with 5 fluorouracil 5 fu and escalating doses of carboplatin cbdca plus recombinant human granulocyte macrophage colony stimulating factor gm csf. Proceedings of the American Association for Cancer Research Annual Meeting 33: 224

A phase i ii study of iodine 131 mibg in chemo resistant neuroblastoma. Evans, A E , Et Al (Ed ) Progress in Clinical And Biological Research, Vol 366 Advances in Neuroblastoma Research 3; Fifth Symposium, Philadelphia, Pennsylvania, Usa, May 28-30, 1990 Xxxi+633p John Wiley And Sons, Inc : New York, New York, Usa; Chichester, England, Uk Illus 463-470

A phase i ii study of navelbine nvb by 96 hours continuous infusion civ in metastatic breast cancer mbc. Breast Cancer Research & Treatment 19(2): 169

A phase i ii study of oral ifosfamide to determine its tolerance and effectiveness in advanced non small cell lung cancer. Queisser, W And H H Fiebig (Ed ) Contributions to Oncology, Vol 37 New Drugs in Oncology; Symposium Of The Phase Ii Study Group Of The Association For Medical Oncology Of The German Cancer Society, Frankfurt/Main, West Germany, November 17-18, 1988 Ix+302p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 207-212

A phase i ii study of the toxicity immunogenicity and efficacy of recombinant gp160 and p24 vaccines vaxsyn in hiv infected individuals regardless of cd4 positive cell count. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : tu39

A phase i ii study of the use of fluosol da 20 percent as an adjuvant to radiation therapy in the treatment of primary high grade brain tumors. International Journal of Radiation Oncology, Biology, Physics 17(SUPPL 1): 175-176

A phase i ii study of zidovudine interferon alpha and granulocyte macrophage colony stimulating factor in treatment of hiv 1 infection. Clinical Research 38(2): 280A

A phase i ii trial of accelerated fractionation in non small cell lung cancer. Clinical & Investigative Medicine 15(4 SUPPL): A137

A phase i ii trial of erythropoietin epoetin beta epo in patients with myelodysplastic syndromes mds. Leukemia Research 15(SUPPL): 13

A phase i ii trial of recombinant human interleukin 3 rhu il 3 added to cyclosporine and antilymphocyte globulin alg in patients with refractory severe aplastic anemia. Onkologie 14(SUPPL 2): 129

A phase i ii trial of the combination of zidovudine and interleukin 2 in the treatment of hiv related kaposis sarcoma. Morisset, R A Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 407

A phase i ii trial of zidovudine interferon alpha and granulocyte macrophage colony stimulating factor in treatment of hiv 1 infection. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb420

A phase i ii unblinded dose ranging study of hypericin in hiv positive subjects. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 199b

A phase i iia study of a human monoclonal anti cytomegalovirus antibody in patients with aids. Antiviral Research 17(SUPPL 1): 111

A phase i multiple dose study of u 87201e a non nucleoside rt inhibitor in normal healthy males. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : we47

A phase i radioimmunoscintigraphy trial of iodine 131 labeled monoclonal antibody g250 in renal cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 33: 219

A phase i radioimmunotherapy trial of iodine 131 labeled monoclonal antibody b 723 for the treatment of peritoneal carcinomatosis. Proceedings of the American Association for Cancer Research Annual Meeting 31: 287

A phase i rtog study of iododeoxyuridine iudr and radiotherapy in the treatment of primary malignant brain tumors. International Journal of Radiation Oncology, Biology, Physics 17(SUPPL 1): 221

A phase i safety and pharmacokinetic study with recombinant human fsh in gonadotropin deficient women. Journal of Endocrinology 132(SUPPL)

A phase i single dose safety evaluation and pharmacokinetic study of nystatin liposomal formulation nystatin lf iv in patients with hiv infection. Viii International Conference on Aids And The Iii Std World Congress Published Abstracts Submitted to The Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, 220p Viii International Congress And The Iii Std World Congress: Amsterdam, Netherlands Paper : 127

A phase i study including pharmacokinetics of peg il 2 in patients with advanced cancer. Clinical Research 37(1): 163A

A phase i study of 2 3 dideoxyinosine ddi administered orally twice daily to patients with aids or arc and hematologic intolerance to azidothymidine azt. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb473

A phase i study of a unique schedule of dacarbazine and carmustine. Proceedings of the American Association for Cancer Research Annual Meeting 33: 236

A phase i study of alpha interferon ifn alpha in combination with interleukin 2 il 2 in patients with hiv infection. Clinical Research 40(2): 246A

A phase i study of autologous activated cd8 positive lymphocytes expanded in vitro infused into patients with advanced arc or aids actg 080. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb491

A phase i study of depofoam ara c in the treatment of carcinomatous meningitis. Neurology 42(4 SUPPL 3): 388-389

A phase i study of escalating dose trental with cisplatin in advanced or recurrent gynecologic cancer a chemomodulation regimen. Gynecologic Oncology 45(1): 84

A phase i study of fluorouracil leucovorin and levamisole. Proceedings of the American Association for Cancer Research Annual Meeting 33: 244

A phase i study of glq223 in subjects with aids and arc. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb465

A phase i study of gm csf cyclophosphamide and escalating doses of carboplatin with and without cyclophosphamide in chemotherapy naive patients with carcinoma of the ovary. Anti-Cancer Drug Design 6(4): 356

A phase i study of gm csf cyclophosphamide cp and escalating doses of carboplatin cbdca in chemotherapy naive patients with ovarian cancer. Gynecologic Oncology 40(2): 169-170

A phase i study of high dose il 2 cetus with interferon alpha 2b. Proceedings of the American Association for Cancer Research Annual Meeting 31: 264

A phase i study of ifosfamide ifx and carboplatin cb with bone marrow transplantation. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 2): 822

A phase i study of infusion of monoclonal antibodies mab5 against the v3 region in patients with severe hiv infection. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 218b

A phase i study of intraperitoneal chip in minimal residual epithelial ovarian cancer. Investigational New Drugs 7(4): 405

A phase i study of liposomal gentamicin. Viii International Conference on Aids And The Iii Std World Congress Published Abstracts Submitted to The Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, 220p Viii International Congress And The Iii Std World Congress: Amsterdam, Netherlands Paper : 113

A phase i study of liposome encapsulated gentamicin for treatment of mai bacteremia in aids patients. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 267b

A phase i study of n phosphonacetyl l aspartate pala methotrexate mtx 5 fluorouracil fu with leucovorin and uridine rescues. Proceedings of the American Association for Cancer Research Annual Meeting 30: 244

A phase i study of radiolabeled oc 125 in the treatment of recurrent epithelial ovarian cancer. Gynecologic Oncology 32(1): 107

A phase i study of recombinant cd 4 pseudomonas exotoxin cd4 pe40 in hiv infected individuals. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : mo8

A phase i study of recombinantly produced herpes simplex virus hsv glycoproteins gd2 and gb2 combined with a novel adjuvant mf59 mtp pe. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 349

A phase I study of regionally administered mitomycin microcapsules for patients with colorectal liver metastases. European Journal of Cancer 27(9): 1189-1190

A phase i study of taxol given as a 6 hour infusion every 21 days. Investigational New Drugs 7(4): 451

A phase i study of the anti egfr monoclonal antibody 425 in patients with malignant gliomas. Neurology 41(3 SUPPL 1): 383

A phase i study of the pharmacokinetics and safety of zidovudine in third trimester hiv 1 infected pregnant women and their infants. Pediatric Research 31(4 PART 2): 173A

A phase i study of the potential antineoplastic compound bzq 2 5 diaziridinyl 3 6 bis 2 hydroxyethylamino 1 4 benzoquinone nsc 224070. Investigational New Drugs 7(4): 454

A phase i study of the safety and immunogenicity of typ24vlp in healthy volunteers. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : a43

A phase i study of the safety and pharmacokinetics of soluble recombinant cd4 r cd4 in patients with aids and arc. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 337

A phase i study of zidovudine azt and dideoxyinosine ddi in children with hiv infection. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 178

A phase i study on high dose epirubicin. Investigational New Drugs 7(4): 392

A phase i study to evaluate the tolerance and safety of glq223 in hiv positive individuals. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 202b

A phase i study with an ifosfamide carboplatin and etoposide regimen in advanced non small cell lung cancer an interim analysis. Hossfeld, D K (Ed ) Contributions to Oncology, Vol 35 Ifosfamide in The Treatment Of Lung Cancer; Satellite Symposium Of The 19th German Cancer Congress, Frankfurt, West Germany, February 28, 1988 Vii+154p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 85-90

A phase i study with pharmacokinetics of prolonged ambulatory infusion carboplatin. Proceedings of the American Association for Cancer Research Annual Meeting 33: 537

A phase i trial of 2 chlorodeoxyadenosine 2 cda in childhood leukemias. Pediatric Research 25(4 PART 2): 156A

A phase i trial of 773u82 hydrochloride administered 24 or 48 hour continuous infusion every 28 days. Proceedings of the American Association for Cancer Research Annual Meeting 31: 181

A phase i trial of a 120 hour infusion of 5 fluorouracil leucovorin and dipyridamole. Proceedings of the American Association for Cancer Research Annual Meeting 31: 198

A phase i trial of adozelesin a novel dna sequence specific alkylating agent. Proceedings of the American Association for Cancer Research Annual Meeting 33: 520

A phase i trial of bone marrow purging in acute leukemia with alkyl lysophospholipid alp. Experimental Hematology (Charlottesville) 19(6): 557

A phase i trial of brequinar dup 785 in combination with cisplatin in patients with refractory solid tumors. Proceedings of the American Association for Cancer Research Annual Meeting 32: 201

A phase i trial of chronic oral navelbine administration. Proceedings of the American Association for Cancer Research Annual Meeting 33: 519

A phase i trial of dideoxyinosine in pediatric hiv infection cerebrospinal fluid and plasma pharmacokinetics. Pediatric Research 29(4 PART 2): 184A

A phase i trial of droloxifene d in thirty patients pts with metastatic breast cancer mbc. Proceedings of the American Association for Cancer Research Annual Meeting 33: 260

A phase i trial of high dose acetaminophen hdacet with n acetylcysteine nac rescue for advanced malignancies. Proceedings of the American Association for Cancer Research Annual Meeting 33: 520

A phase i trial of high dose carboplatin plus etoposide plus dose escalation of cyclophosphamide with autologous bone marrow rescue in patients with refractory germ cell tumors. Proceedings of the American Association for Cancer Research Annual Meeting 32: 171

A phase i trial of high dose carboplatinum cbdca and etoposide vp 16 followed by autologous transplantation in recurrent childhood tumors. Journal of Cellular Biochemistry Supplement (14 PART A): 323

A phase i trial of high dose r24 mouse monoclonal antibody in patients with metastatic melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 32: 265

A phase i trial of interleukin 1 alpha il 1 alpha alone and in combination with indomethacin. Lymphokine Research 9(4): 568

A phase i trial of intraperitoneally administered recombinant macrophage colony stimulating factor rm csf in cancer patients. Onkologie 14(SUPPL 2): 65-66

A phase i trial of intravenous procysteine in hiv infected subjects. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b162

A phase i trial of intravenously administered endotoxin salmonella abortus equi in patients with advanced cancer. Proceedings of the American Association for Cancer Research Annual Meeting 32: 268

A phase i trial of laboratory derived synergistic chemotherapeutic sc combination 2 deoxy 5 azacytidine dac and cisplatin cddp. Proceedings of the American Association for Cancer Research Annual Meeting 32: 204

A phase i trial of n phosphonacetyl l aspartate methotrexate mtx 5 fluorouracil with leucovorin and uridine rescues. Proceedings of the American Association for Cancer Research Annual Meeting 32: 184

A phase i trial of novobiocin n and cyclophosphamide cpa. Proceedings of the American Association for Cancer Research Annual Meeting 31: 180

A phase i trial of oral menogaril tut 7. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 578

A phase I trial of preoperative radiation, proctectomy, and endoanal reconstruction. Archives of Surgery 125(2): 247-251

A phase i trial of prophylactic aerosolized amphotericin b in patients at risk for prolonged neutropenia. Clinical Research 39(3): 747A

A phase i trial of recombinant human cd4 immunoglobulin rcd4 igg in hiv 1 infection. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb481

A phase i trial of recombinant human interleukin 3 rh il 3 in patients with myelodysplastic syndrome mds and aplastic anemia aa. Leukemia Research 15(SUPPL): 14

A phase i trial of streptozotocin stz followed by bcnu. Proceedings of the American Association for Cancer Research Annual Meeting 30: 275

A phase i trial of subcutaneous interleukin 2 and interleukin 4. Proceedings of the American Association for Cancer Research Annual Meeting 33: 231

A phase i trial of topotecan topo administered by a 24 hour infusion. Proceedings of the American Association for Cancer Research Annual Meeting 32: 206

A phase i trial with pharmacokinetics of hepsulfam. Proceedings of the American Association for Cancer Research Annual Meeting 32: 201

A phase i trial with recombinant human granulocyte macrophage colony stimulating factor derived from yeast rhugm csf in patients with breast cancer receiving caf chemotherapy in adjuvant and metastatic disease. Breast Cancer Research & Treatment 19(2): 168

A phase i/ii study of oral matrix metalloproteinase inhibitor, marimastat, in patients with inoperable gastric cancer. Gastroenterology 112(4 SUPPL ): A636

A phase ia ib trial of continuous infusion ci interleukin 4 alone and following interleukin 2 in cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 33: 347

A phase ib trial of anti cd3 okt3 and low dose continuous infusion ci interleukin 2 il 2 in cancer patients an approach to enhance t cell activation. Journal of Cellular Biochemistry Supplement (16 PART B): 317

A phase ib trial of murine monoclonal antibody r 24 anti gd3 in metastatic melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 33: 340

A phase ii chronopharmacological trial of oxaliplatin l ohp against metastatic colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 32: 185

A phase ii clinical trial of adjuvant cytotoxic monoclonal antibodies in canine lymphoma. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 609

A phase ii clinical trial of recombinant human granulocyte stimulating factor in the myelodysplastic syndromes and aplastic anemia. Experimental Hematology (Charlottesville) 18(6): 605

A phase ii clinical trial of recombinant interleukin 2 plus systemic roferon a for recurrent primary and metastatic brain tumor. Proceedings of the American Association for Cancer Research Annual Meeting 31: 266

A phase ii clinical trial of vs103 liposomal daunorubicin in kaposis sarcoma in aids patients. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b104

A phase ii clinical trial with bleomycin cisplatin vp 16 and prednisone in recurrent squamous head and neck carcinoma. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 705

A phase ii evaluation of cisplatin and 5 fluorouracil in patients with advanced squamous cell carcinoma of the cervix. Gynecologic Oncology 32(1): 116

A phase ii evaluation of mitoxantrone hydrochloride in the treatment of progressive multiple sclerosis. Neurology 41(3 SUPPL 1): 146

A phase II multicenter evaluation of several candidate pertussis vaccines in infants. Developments in Biological Standardization 73: 305-309

A phase ii multicenter study pirarubicin 4 o tetrahydropyranyladriamycin thp in advanced breast cancer. Investigational New Drugs 7(4): 426

A phase ii open study of zofran in platinum containing regiments. European Journal of Cancer 27(SUPPL 3): S74

A phase ii pilot study of murine anti idiotypic monoclonal antibodies in patients with malignant melanoma. Investigational New Drugs 7(4): 415

A phase ii study activity of pirarubicin 4 o tetrahydropyranyladriamycin thp in advanced breast cancer. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 714

A phase ii study evaluating trimetrexate in metastatic breast cancer. Breast Cancer Research & Treatment 16(2): 157

A phase ii study of 5 fluorouracil infusion and interferon alpha in metastatic sarcomas. Proceedings of the American Association for Cancer Research Annual Meeting 33: 229

A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer. European Journal of Cancer & Clinical Oncology 25(10): 1509-1510

A phase ii study of bisantrene adca in advanced breast cancer abc 2nd line regimen. Breast Cancer Research & Treatment 19(2): 192

A phase ii study of bleomycin pleurodesis in japan. American Review of Respiratory Disease 143(4 PART 2): A661

A phase ii study of carrisyn c acemannan alone and with azt among symptomatic and asymptomatic hiv patients p. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb469

A phase ii study of combination chemotherapy with etoposide adriamycin and cisplatin eap for advanced gastric cancer in japan. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 673

A phase ii study of cyclophosphamide epirubicin and etoposide cee combination in small cell lung cancer sclc. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 117

A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas. European Journal of Cancer 28a(8-9): 1590-1590

A phase ii study of futraful ft 207 suppository for head and neck cancer. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 580

A phase ii study of gemcitabine in non small cell lung cancer nsclc using a twice weekly schedule. Proceedings of the American Association for Cancer Research Annual Meeting 33: 226

A phase ii study of hepatic intraarterial fotemustine final report among 66 evaluable patients. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 692

A phase II study of high dose ifosfamide in metastatic colorectal cancer. European Journal of Cancer & Clinical Oncology 25(1): 139-140

A phase II study of ifosfamide in endometrial cancer. Cancer ChemoTherapy and Pharmacology 26 Suppl: S4-S6

A phase ii study of interferon alfa 2b treatment of anti hcv positive and negative chronic nanb hepatitis interim analysis. Journal of Hepatology 11(SUPPL 1): S165

A phase ii study of iproplatin in advanced or metastatic stomach cancer. European Journal of Cancer 26(1): 61-62

A phase ii study of leuprorelin acetate depot tap 144 sr in patients with advanced prostatic cancer. Murphy, G P And S Khoury (Ed ) Progress in Clinical And Biological Research, Vol 303 Therapeutic Progress in Urological Cancers; International Symposium, Paris, France, June 29-July 1, 1988 Xxx+913p Alan R Liss, Inc : New York, New York, Usa Illus 841

A phase ii study of lonidamine in advanced breast cancer. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 33

A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder. European Journal of Cancer & Clinical Oncology 25(2): 391-392

A phase ii study of octreotide in metastatic advanced prostatic cancer mapc. European Journal of Cancer 27(SUPPL 3): S88

A phase ii study of perilymphatically perly injected recombinant r interleukin 2 il 2 in locally far advanced non pretreated head and neck squamous cell carcinoma h and nscc. Proceedings of the American Association for Cancer Research Annual Meeting 30: 360

A phase ii study of recombinant human granulocyte colony stimulating factor in advanced lung cancer patients at risk for chemotherapy induced neutropenia. Proceedings of the American Association for Cancer Research Annual Meeting 30: 408

A phase ii study of recombinant interleukin 2 and alpha interferon roferon for patients with advanced renal cell cancer. Proceedings of the American Association for Cancer Research Annual Meeting 32: 187

A phase ii study of the effect of trichosanthin treatment in combination with zidovudine in hiv disease. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 224b

A phase ii study of the pineal hormone melatonin mlt in non responder metastatic solid tumors. Investigational New Drugs 7(4): 419

A phase ii study of the second line treatment of advanced ovarian cancer with iproplatin a southwest oncology group study. Investigational New Drugs 7(4): 428

A phase ii study of topical graduated steroids in the management of hpv associated vulvodynia. International Journal of Gynecology & Obstetrics (ABSTR SUPPL): 131

A phase II study of toremifene in carcinoma corporis uteri. Preliminary communication. Journal of Steroid Biochemistry 36(3): 241-241

A phase II study of trimetrexate therapy for metastatic colorectal carcinoma. Cancer Investigation 8(6): 619-621

A phase ii study of vinorelbine nvb in patients pts with advanced breast cancer bc. Proceedings of the American Association for Cancer Research Annual Meeting 30: 256

A phase ii study of virulizin in patients with pancreatic cancer. Clinical & Investigative Medicine 15(4 SUPPL): A89

A phase ii study of vp 16 213 and cisplatin in advanced esophageal cancer. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 1): 649

A phase ii study of whole body hyperthermia wbh with mitomycin c mito c and continuous intravenous civ 5 fluorouracil in colon cancer. Proceedings of the American Association for Cancer Research Annual Meeting 33: 250

A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer. European Journal of Cancer 27(4): 520-521

A phase ii study with pharmacokinetics of gallium nitrate in non small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 32: 190

A phase ii trial of carbetimer in metastatic colorectal cancer a trial of the northern california oncology group ncog. Proceedings of the American Association for Cancer Research Annual Meeting 30: 256

A phase II trial of continuous infusion vinblastine in patients with gastric carcinoma. A Southwest Oncology Group study. European Journal of Cancer 26(3): 405-407

A phase II trial of echinomycin in metastatic cervix carcinoma. Investigational New Drugs 8(3): 311-312

A phase ii trial of fluconazole plus flucytosine for cryptococcal meningitis. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 266b

A phase ii trial of interferon alpha 2a plus 5 fluorouracil in advanced renal cell carcinoma a hoosier oncology group study. Clinical Research 39(3): 747A

A phase II trial of oral idarubicin plus dibromodulcitol in advanced breast cancer. European Journal of Cancer & Clinical Oncology 25(1): 141-143

A phase ii trial of recombinant interleukin 2 by continuous infusion in advanced renal cell carcinoma. Journal of Urology 143(4 SUPPL): 319A

A phase ii trial of suramin in patients with advanced renal cell carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 33: 220

A phase ii trial of tamoxifen therapy for recurrent malignant glioma. Proceedings of the American Association for Cancer Research Annual Meeting 32: 180

A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung. European Journal of Cancer & Clinical Oncology 25(12): 1881-1885

A phase ii trial testing 6 aminochrysene 6 ac entrapped into sonicated liposomes in advanced breast cancer patients pts with liver metastasis and including a biodistribution study of the liposomes. Proceedings of the American Association for Cancer Research Annual Meeting 30: 272

A phase ii trial with alpha ifn and natural gamma ifn in patients with advanced stages of malignant carcinoid tumors. Journal of Interferon Research 10(SUPPL 1): S128

A phase ii trial with d tryptophan 6 decapeptyl in premenopausal rh positive hormonal untreated advanced breast cancer patients. Breast Cancer Research & Treatment 16(2): 175

A phase iii open randomized study of zoladex 36 mg depot vs des 3 mg per day in untreated advanced prostate cancer a west midlands england uk urological research group study. Murphy, G P And S Khoury Progress in Clinical And Biological Research, Vol 303 Therapeutic Progress in Urological Cancers; International Symposium, Paris, France, June 29-July 1, 1988 Xxx+913p Alan R Liss, Inc : New York, New York, Usa Illus 47-52

A phase iii randomized study comparing multiple drug chemotherapy versus standard combination for small cell lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 33: 225

A phase iii study of thoracic radiation with or without concurrent cisplatin chemotherapy in locoregional unresectable non small cell carcinoma of the lung a hoosier oncology group protocol. International Journal of Radiation Oncology, Biology, Physics 21(SUPPL 1): 136

A phase iii trial comparing orchidectomy vs orchidectomy and cyproterone acetate and low dose stilbestrol in the management of metastatic carcinoma of the prostate eortc protocol 30805. Proceedings of the American Association for Cancer Research Annual Meeting 30: 309

A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate. Cancer 66(5 Suppl): 1058-1066

A phase lb study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours. British Journal of Cancer 97(10): 1338-1343

A phase microscopy study on the effect of sarkomycin upon dividing spermatocytes of grasshoppers. Japanese Jour Genetics 31(7): 197-200

A phase model of transitions Cognitive and motivational consequences. Zanna, M P Advances in Experimental Social Psychology 163-214

A phase of alluvial sedimentation during the early Preboreal in Escaut Valley, northern France. Quaternaire (Paris) 13(2): 149-152

A phase of geographical variation in some species of Cisticola. Bull British Ornith Club 48(317): 28-31

A phase of the autonomic nervous system in obstetrics and gynecology. Surgery, Gynecology & Obstetrics 107(6): 744-748

A phase one clinical trial of intra-articular ketorolac in acute gout arthritis. Arthritis & Rheumatism 41(9 SUPPL ): S152, Sept

A phase one increasing dose trial of oral ribavirin rbv in patients with aids and arc. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb468

A phase one study of zidovudine azt in infants less than three months old at risk for hiv infection. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 203

A phase principle for complex-frequency analysis and its implications in auditory theory. Jour Acoustical Soc Amer 24(6): 582-589

A phase response curve for the benzodiazepine chlordiazepoxide and the effect of geniculo hypothalamic tract ablation. Society for Neuroscience Abstracts 17(1-2): 666

A phase sensitive parameetric seismometer. Bulletin of the Seismological Society of America 56(4): 947-959

A phase signature for detecting subsurface moisture using polarimetric L-band SAR; example of the Pyla Dune, France. International Geoscience and Remote Sensing Symposium 2003, Volume 4(Pages 2897-2899

A phase synchronization clustering algorithm for identifying interesting groups of genes from cell cycle expression data. Bmc Bioinformatics 9: 56-56

A phase three trial daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia. Seminars in Oncology 16(1 suppl ): 21-24

A phase unwrapping method based on network programming. ESA SP European Space Agency Special Publication

A phase-1 dose-escalating study of the combination of didanosine plus ribavirin in HIV-infected children. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 364

A phase-I study of R 89439, a potent alpha-APA RT-inhibitor on HIV-1 negative and HIV-1 positive volunteers. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 481